Arizona accuses drugmaker Insys of fraudulent opioid marketing

(Reuters) – Arizona sued Insys Therapeutics Inc on Thursday, accusing the drugmaker of engaging in a fraudulent marketing scheme aimed at increasing sales of a fentanyl-based cancer pain medicine called Subsys.

Leave a Reply

Your email address will not be published. Required fields are marked *